Search CommunityWalk:


Synthetic Biologics

155 Gibbs Street #412
Rockville, MD 20850, US
(734) 332-7800

Category: Biotechnology/Biopharmaceutical

Used in the following map:

Maryland Biotech Industry Map

Founded in 2001, with offices in Rockville, Maryland, Synthetic Biologics, Inc. trades on the NYSE MKT, LLC under the symbol "SYN".

Synthetic Biologics is a biotechnology company focused on the development of synthetic biologics and innovative medicines for serious infections and diseases. Synthetic Biologics is developing a biologic for the prevention of C. diff infection, and a series of monoclonal antibodies (mAbs) for the treatment of serious infectious diseases, including pertussis and Acinetobacter. The Company is also develoing a synthetic DNA-based therapy for the treatment of pulmonary arterial hypertension (PAH).

In addition, Synthetic Biologics is developing a product candidate to treat relapsing-remitting multiple sclerosis (MS) and cognitive dysfunction in MS; designing a clinical development pathway for the treatment of amyotrophic lateral sclerosis (ALS); and, has partnered the development of a treatment for fibromyalgia. The Company is also evaluating additional in-licensing opportunities.